Literature DB >> 33675433

Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know?

Zhi-Min Zou1, De-Hua Chang2, Hui Liu1, Yu-Dong Xiao3.   

Abstract

With the development of machine learning (ML) algorithms, a growing number of predictive models have been established for predicting the therapeutic outcome of patients with hepatocellular carcinoma (HCC) after various treatment modalities. By using the different combinations of clinical and radiological variables, ML algorithms can simulate human learning to detect hidden patterns within the data and play a critical role in artificial intelligence techniques. Compared to traditional statistical methods, ML methods have greater predictive effects. ML algorithms are widely applied in nearly all steps of model establishment, such as imaging feature extraction, predictive factor classification, and model development. Therefore, this review presents the literature pertaining to ML algorithms and aims to summarize the strengths and limitations of ML, as well as its potential value in prognostic prediction, after various treatment modalities for HCC.

Entities:  

Keywords:  Hepatocellular carcinoma; Machine learning; Modality; Predictive

Year:  2021        PMID: 33675433     DOI: 10.1186/s13244-021-00977-9

Source DB:  PubMed          Journal:  Insights Imaging        ISSN: 1869-4101


  69 in total

Review 1.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

2.  AASLD guidelines for the treatment of hepatocellular carcinoma.

Authors:  Julie K Heimbach; Laura M Kulik; Richard S Finn; Claude B Sirlin; Michael M Abecassis; Lewis R Roberts; Andrew X Zhu; M Hassan Murad; Jorge A Marrero
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

3.  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.

Authors:  Isabel Theresa Schobert; Lynn Jeanette Savic; Julius Chapiro; Khaled Bousabarah; Evan Chen; Fabian Laage-Gaupp; Jonathan Tefera; Nariman Nezami; MingDe Lin; Jeffrey Pollak; Todd Schlachter
Journal:  Eur Radiol       Date:  2020-05-19       Impact factor: 5.315

4.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

5.  Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma.

Authors:  Jeongin Yoo; Min Woo Lee; Dong Ho Lee; Jeong-Hoon Lee; Joon Koo Han
Journal:  Liver Int       Date:  2020-03-13       Impact factor: 5.828

6.  Role of baseline volumetric functional MRI in predicting histopathologic grade and patients' survival in hepatocellular carcinoma.

Authors:  Sanaz Ameli; Mohammadreza Shaghaghi; Mounes Aliyari Ghasabeh; Pallavi Pandey; Bita Hazhirkarzar; Maryam Ghadimi; Roya Rezvani Habibabadi; Pegah Khoshpouri; Ankur Pandey; Robert A Anders; Ihab R Kamel
Journal:  Eur Radiol       Date:  2020-03-06       Impact factor: 5.315

7.  A Predictive Model for Postembolization Syndrome after Transarterial Hepatic Chemoembolization of Hepatocellular Carcinoma.

Authors:  Mohamed H Khalaf; Vandana Sundaram; Mohammed Ahmed AbdelRazek Mohammed; Rajesh Shah; Ankaj Khosla; Katherine Jackson; Manisha Desai; Nishita Kothary
Journal:  Radiology       Date:  2018-10-09       Impact factor: 11.105

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.

Authors:  Tim A Labeur; Sarah Berhane; Julien Edeline; Jean-Frederic Blanc; Dominik Bettinger; Tim Meyer; Jeroen L A Van Vugt; David W G Ten Cate; Robert A De Man; Ferry A L M Eskens; Alessandro Cucchetti; Laura J Bonnett; Otto M Van Delden; Heinz-Josef Klümpen; R Bart Takkenberg; Philip J Johnson
Journal:  Liver Int       Date:  2019-11-18       Impact factor: 5.828

10.  A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function.

Authors:  Joon Yeul Nam; A Reum Choe; Dong Hyun Sinn; Jeong-Hoon Lee; Hwi Young Kim; Su Jong Yu; Yoon Jun Kim; Jung-Hwan Yoon; Jeong Min Lee; Jin Wook Chung; Sun Young Choi; Jeong Kyong Lee; Seung Yon Baek; Hye Ah Lee; Tae Hun Kim; Kwon Yoo
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

View more
  3 in total

1.  A Machine Learning Model Based on Health Records for Predicting Recurrence After Microwave Ablation of Hepatocellular Carcinoma.

Authors:  Chao An; Hongcai Yang; Xiaoling Yu; Zhi-Yu Han; Zhigang Cheng; Fangyi Liu; Jianping Dou; Bing Li; Yansheng Li; Yichao Li; Jie Yu; Ping Liang
Journal:  J Hepatocell Carcinoma       Date:  2022-07-28

2.  Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis.

Authors:  Grace Lai-Hung Wong; Vicki Wing-Ki Hui; Qingxiong Tan; Jingwen Xu; Hye Won Lee; Terry Cheuk-Fung Yip; Baoyao Yang; Yee-Kit Tse; Chong Yin; Fei Lyu; Jimmy Che-To Lai; Grace Chung-Yan Lui; Henry Lik-Yuen Chan; Pong-Chi Yuen; Vincent Wai-Sun Wong
Journal:  JHEP Rep       Date:  2022-01-22

3.  Stemness Analysis Uncovers That The Peroxisome Proliferator-Activated Receptor Signaling Pathway Can Mediate Fatty Acid Homeostasis In Sorafenib-Resistant Hepatocellular Carcinoma Cells.

Authors:  Tingze Feng; Tianzhi Wu; Yanxia Zhang; Lang Zhou; Shanshan Liu; Lin Li; Ming Li; Erqiang Hu; Qianwen Wang; Xiaocong Fu; Li Zhan; Zijing Xie; Wenqin Xie; Xianying Huang; Xuan Shang; Guangchuang Yu
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.